School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan Province 450001, China.
Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou, Henan Province 450001, China.
ACS Appl Mater Interfaces. 2020 Jul 29;12(30):33473-33482. doi: 10.1021/acsami.0c06785. Epub 2020 Jul 14.
Tumor-derived exosomes are emerging noninvasive biomarker reservoirs that reflect biological information from their parental cells, especially specific markers, including proteins, DNA fragments and RNAs. Recently, analytical methods of tumor-derived exosomes have been increasing growth. However, developing a convenient signal amplification technique to improve the sensitivity of exosomes detection still remains a challenge. Herein, an ultrasensitive and specific exosomes diagnostic biochip is constructed and further applied to circulating tumor exosomes detection in serum. Using an exosomes diagnostic biochip, signal amplification is achieved by combining the advantages of quantum dots with the biomimetic periodic nanostructure of photonic crystals. Glypican-1 (GPC1), a membrane-anchored protein that is overexpressed in exosomes from pancreatic cancer, is detected using nanosized molecular beacons with high luminescence efficiency; then the signal is amplified through photonic crystals. Moreover, the method allows the quantitative analysis of various disease-specific surface proteins on exosomes. We believe that this exosomes diagnostic biochip is likely to have potential as an effective bioassay, which may be helpful for quantification of disease-specific exosomes in clinical use.
肿瘤来源的外泌体是一种新兴的非侵入性生物标志物库,反映了其亲本细胞的生物学信息,特别是特定的标志物,包括蛋白质、DNA 片段和 RNA。最近,肿瘤来源的外泌体的分析方法不断增加。然而,开发一种方便的信号放大技术来提高外泌体检测的灵敏度仍然是一个挑战。本研究构建了一种超灵敏和特异的外泌体诊断生物芯片,并进一步应用于血清中循环肿瘤外泌体的检测。利用外泌体诊断生物芯片,通过将量子点的优势与光子晶体的仿生周期性纳米结构相结合,实现了信号的放大。糖蛋白 1(GPC1)是一种膜锚定蛋白,在胰腺癌来源的外泌体中过度表达,使用具有高光致发光效率的纳米分子信标进行检测;然后通过光子晶体进行信号放大。此外,该方法允许对外泌体上各种疾病特异性表面蛋白进行定量分析。我们相信,这种外泌体诊断生物芯片很可能具有作为有效生物测定的潜力,这可能有助于在临床应用中对外泌体进行疾病特异性的定量分析。